Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Twist Bioscience Corporation (TWST) Misses Q4 EPS by 11c
December 11, 2019 4:11 PM ESTTwist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.96), $0.11 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $15.7 million versus the consensus estimate of $14.06 million.
GUIDANCE:
Twist Bioscience Corporation sees FY2020 revenue of $80-84 million, versus... More
